Evidence map›Paper›PMID 36677441›Full record

ArticleMicroorganisms2023

Molecular and Source-Specific Profiling of Hospital

Kamaleldin B Said, Naif Saad Alghasab, Mohammed S M Alharbi, Ahmed Alsolami, Mohd Saleem, Sulaf A Alhallabi, Shahad F Alafnan, Azharuddin Sajid Syed Khaja, Taha E Taha, On Behalf Of The Ha'il Com Research Unit Group

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Kamaleldin B SaidDepartment of Pathology, College of Medicine, University of Ha'il, Ha'il 55476, Saudi Arabia.ORCID 0000-0002-3749-6754
Naif Saad AlghasabDepartment of Cardiology, College of Medicine, University of Ha'il, Ha'il 55476, Saudi Arabia.
Mohammed S M AlharbiDepartment of Internal Medicine, College of Medicine, University of Ha'il, Ha'il 55476, Saudi Arabia.
Ahmed AlsolamiDepartment of Internal Medicine, College of Medicine, University of Ha'il, Ha'il 55476, Saudi Arabia.
Mohd SaleemDepartment of Pathology, College of Medicine, University of Ha'il, Ha'il 55476, Saudi Arabia.ORCID 0000-0003-2813-6279
Sulaf A AlhallabiDepartment of Pathology, College of Medicine, University of Ha'il, Ha'il 55476, Saudi Arabia.
Shahad F AlafnanDepartment of Pathology, College of Medicine, University of Ha'il, Ha'il 55476, Saudi Arabia.
Azharuddin Sajid Syed KhajaDepartment of Pathology, College of Medicine, University of Ha'il, Ha'il 55476, Saudi Arabia.ORCID 0000-0003-1594-1826
Taha E TahaDepartment of Epidemiology, John Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
On Behalf Of The Ha'il Com Research Unit Group
University of Ha'il · SAJohns Hopkins University · US

Funding

University of Hail RG20184
6 · The paper itself

Abstract

Staphylococcus aureus is a major human-associated pathogen that causes a wide range of clinical infections. However, the increased human dynamics and the changing epidemiology of the species have made it imperative to understand the population structure of local ecotypes, their transmission dynamics, and the emergence of new strains. Since the previous methicillin-resistant S. aureus (MRSA) pandemic, there has been a steady increase in global healthcare-associated infections involving cutaneous and soft tissue and resulting in high morbidities and mortalities. Limited data and paucity of high-quality evidence exist for many key clinical questions about the pattern of S. aureus infections. Using clinical, molecular, and epidemiological characterizations of isolates, hospital data on age and infection sites, as well as antibiograms, we have investigated profiles of circulating S. aureus types and infection patterns. We showed that age-specific profiling in both intensive care unit (ICU) and non-ICU revealed highest infection rates (94.7%) in senior-patients > 50 years; most of which were MRSA (81.99%). However, specific distributions of geriatric MRSA and MSSA rates were 46.5% and 4.6% in ICU and 35.48% and 8.065% in non-ICU, respectively. Intriguingly, the age groups 0−20 years showed uniquely similar MRSA patterns in ICU and non-ICU patients (13.9% and 9.7%, respectively) and MSSA in ICU (11.6%). The similar frequencies of both lineages in youth at both settings is consistent with their increased socializations and gathering strongly implying carriage and potential evolutionary replacement of MSSA by MRSA. However, in age groups 20−50 years, MRSA was two-fold higher in non-ICU (35%) than ICU (18.6%). Interestingly, a highly significant association was found between infection-site and age-groups (p-value 0.000). Skin infections remained higher in all ages; pediatrics 32.14%, adults 56%, and seniors 25% while respiratory infections were lower in pediatrics (14.3%) and adults (17%) while it was highest in seniors (38%). Blood and “other” sites in pediatrics were recorded (28.6%; 25%, respectively), and were slightly lower in adults (18.6%; 8.6%) and seniors (14%; 22.8%), respectively. Furthermore, a significant association existed between infection-site and MRSA (Chi-Square Test, p-value 0.002). Thus, the common cutaneous infections across all age-groups imply that skin is a significant reservoir for endogenous infections; particularly, for geriatrics MRSA. These findings have important clinical implications and in understanding S. aureus profiles and transmission dynamics across different age groups that is necessary for strategic planning in patient management and infection control.

Indexed as

clinical S. aureusendogenous-S. aureusgeriatric-MRSA pneumoniaMSSA and MRSA lineagesskin carriage

Identifiers

PMID36677441
PMCPMC9862673
OpenAlexW4313890926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.